Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $82.14 USD
Change Today +1.17 / 1.44%
Volume 3.7M
ESRX On Other Exchanges
ESRX is not on other exchanges.
As of 8:10 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

express scripts holding co (ESRX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - $94.61
52 Week Low
08/24/15 - $68.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

express scripts holding co (ESRX) Details

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

29,500 Employees
Last Reported Date: 02/23/15
Founded in 1986

express scripts holding co (ESRX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $535.4K
Vice President
Total Annual Compensation: $332.0K
Compensation as of Fiscal Year 2014.

express scripts holding co (ESRX) Key Developments

Express Scripts Holding Company Announces Management Changes

Express Scripts Holding Company announced Eric Slusser has joined the company as Executive Vice President and Chief Financial Officer, effective September 9, 2015. Mr. Slusser joins Express Scripts with significant experience as a financial executive in health care, bringing executive-level and functional experience in all aspects of finance including strategy, capital markets, mergers and acquisitions, financial reporting, planning and investor relations. Mr. Slusser was most recently Chief Financial Officer of Gentiva Health Services Inc. Jim Havel, the company's former interim Chief Financial Officer, will continue with Express Scripts as Executive Vice President of Finance for an indeterminate period of time to assist with the transition.

Express Scripts Holding Company Announces Management Changes

Express Scripts Holding Company announced George Paz will retire as Chief Executive Officer, effective following the company's annual meeting of stockholders currently scheduled for May 2016, and current company President Tim Wentworth will take on the role of CEO. Mr. Paz will remain on the Board as non-executive Chairman following his retirement, and Thomas Mac Mahon will continue as Lead Independent Director. Mr. Wentworth was named President of Express Scripts in February 2014. He has management responsibility for all aspects of the company's core business, and currently reports directly to Mr. Paz.

Express Scripts Holding Company Appoints Christopher A. Mcginnis as Vice President, Controller and Chief Accounting Officer, and Principal Accounting Officer

Express Scripts Holding Company announced that effective September 2, 2015, Christopher A. McGinnis, was appointed as the Vice President, Controller and Chief Accounting Officer of the company and as the company's principal accounting officer as defined by the Securities and Exchange Commission. Christopher K. Knibb, who previously served as the principal accounting officer, continues employment at Express Scripts as Vice President, Financial Planning and Analysis. Mr. McGinnis previously served as Vice President, Finance and Investor Relations from August 2014 to August 2015, as Vice President, Legal and Business Development from April 2012 to July 2014, and as Assistant General Counsel from April 2010 to April 2012. Prior to joining Express Scripts in March 2008, Mr. McGinnis held various legal, accounting, and business development roles with previous employers.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESRX:US $82.14 USD +1.17

ESRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $113.11 USD +3.17
Anthem Inc $141.85 USD +2.91
Cardinal Health Inc $78.62 USD +1.50
Kroger Co/The $37.14 USD +0.46
Walgreens Boots Alliance Inc $87.11 USD +2.48
View Industry Companies

Industry Analysis


Industry Average

Valuation ESRX Industry Range
Price/Earnings 27.0x
Price/Sales 0.5x
Price/Book 3.5x
Price/Cash Flow 25.2x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at